Biotech Business - May 11, 2026
Diamyd Medical provides business update
Diamyd Medical has announces that the initial phase of the strategic review, initiated following the discontinuation of the Phase 3 DIAGNODE-3 trial, has been completed.
Collaboration - May 11, 2026
Bactiguard and BD strengthen global partnership
Bactiguard Holding has announced an update to its long standing collaboration with license partner BD (Becton, Dickinson & Company) through the signing of a restated long-term agreement.
Biotech Award - May 11, 2026
These are the winners of the Biotech Stars Awards
The Finnish Bioindustries Biotech Stars Awards were presented at the Made by Cells Biotech Forum on 29 April 2026 at Hanaholmen, Espoo, as part of the celebrations marking the 20th anniversary of Finnish Bioindustries.
Science Award - May 8, 2026
She is the winner of the Novo Nordisk Foundation Nordic Diabetes Prize
Professor Charlotte Ling of Lund University in Sweden has fundamentally changed the scientific understanding of type 2 diabetes by showing that the disease arises through an interplay between genes and environmental influences that alter which genes are active.
Events - May 6, 2026
Northern Sweden’s only dedicated life science lab fair
On May 7, 21 exhibiting companies will take part in Umeå Lab Fair – the event was fully booked in just three hours.
Clinical Trials - May 6, 2026
Spago Nanomedical reports phase I/IIa study data
The independent Data Monitoring Committee (DMC) of the Tumorad-01 study declared that a primary endpoint, identifying the maximum tolerated dose, has been met and recommends that an additional two patients are enrolled at the dose level of 15 MBq/kg to provide a basis for defining a recommended phase II dose and completion of the phase I part of the study.
